Delivery Order SPE2DR25D2206-SPE2DR26F0BHP

<p>The Defense Logistics Agency issued a $69,998.35 delivery order to Amerisourcebergen Drug Corp on February 13, 2026, for Tolvaptan 15 mg tablet unit dose 10s, with an ultimate completion date of February 17, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is priced firm fixed price and carries no set-aside designation.</p>

<p>The Defense Logistics Agency issued a $36,753.02 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for Tolvaptan 30 mg tablets under a firm fixed-price contract with an ultimate completion date of April 21, 2026.</p> <p>Place of performance is Conshohocken, PA. No set-aside was used. The order ceiling matches the obligated value at $36,753.02.</p>

<p>The Defense Logistics Agency issued a $10,876.80 delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Tolvaptan 30 mg tablet unit dose packs.</p> <p>Place of performance is Conshohocken, PA. The order carries an ultimate completion date of February 18, 2026, and is priced on a firm fixed-price basis. No set-aside was used.</p>

The Defense Logistics Agency issued a $47,564.89 delivery order to AmerisourceBergen Drug Corp on April 6, 2026, for Tolvaptan 15 mg tablet unit dose packs (10-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle for military healthcare programs. Place of performance is Conshohocken, Pennsylvania. The order carries a firm fixed...

The Defense Logistics Agency issued a $7,103.08 delivery order to AmerisourceBergen Drug Corp on April 14, 2026, for Tolvaptan 30 mg tablet unit dose packs. This delivery order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide. Place of performance is Conshohocken, Pennsylvania. The order carries firm...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 18, 2026, for Tolvaptan 30 mg tablet UD 10s, with a ceiling value of $1,744.99.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 19, 2026. The order is firm fixed price and carries no set-aside.</p>

The Defense Logistics Agency issued a $3,265.62 delivery order to AmerisourceBergen Drug Corp on March 6, 2026, for Tolvaptan 15 mg tablet unit-dose packs (10s), with ultimate completion on March 9, 2026. The order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order carries...

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 24, 2026, with a ceiling value of $81,473.31 for Tolvaptan 30 mg tablets, unit dose, 10 count.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price and has an ultimate completion date of February 25, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Tolvaptan 15 mg tablets in unit dose packages of 10 units. This is a firm fixed-price delivery order with a ceiling value of $5,100.87 and an ultimate completion date of July 18, 2025. The contract was awarded on a competitive basis without any set-aside designation. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery...

The Defense Logistics Agency awarded a delivery order valued at $21,076.03 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 30 mg tablets in unit-dose packaging of 10 units. This firm fixed-price delivery order, awarded on December 15, 2025, with an ultimate completion date of December 16, 2025, represents a competitive procurement with no set-aside designation. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...